rs16858988

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000817.3(GAD1):​c.1002+387G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.178 in 152,178 control chromosomes in the GnomAD database, including 2,938 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2938 hom., cov: 33)

Consequence

GAD1
NM_000817.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.668

Publications

5 publications found
Variant links:
Genes affected
GAD1 (HGNC:4092): (glutamate decarboxylase 1) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
GAD1 Gene-Disease associations (from GenCC):
  • early infantile epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 89
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 1
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000817.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAD1
NM_000817.3
MANE Select
c.1002+387G>A
intron
N/ANP_000808.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAD1
ENST00000358196.8
TSL:1 MANE Select
c.1002+387G>A
intron
N/AENSP00000350928.3
GAD1
ENST00000493875.5
TSL:1
n.1002+387G>A
intron
N/AENSP00000434696.1
GAD1
ENST00000625689.2
TSL:5
c.1002+387G>A
intron
N/AENSP00000486612.1

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27133
AN:
152060
Hom.:
2937
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0714
Gnomad AMI
AF:
0.181
Gnomad AMR
AF:
0.125
Gnomad ASJ
AF:
0.193
Gnomad EAS
AF:
0.243
Gnomad SAS
AF:
0.333
Gnomad FIN
AF:
0.299
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.221
Gnomad OTH
AF:
0.162
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.178
AC:
27142
AN:
152178
Hom.:
2938
Cov.:
33
AF XY:
0.184
AC XY:
13677
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0712
AC:
2959
AN:
41552
American (AMR)
AF:
0.125
AC:
1905
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.193
AC:
671
AN:
3470
East Asian (EAS)
AF:
0.243
AC:
1257
AN:
5176
South Asian (SAS)
AF:
0.335
AC:
1612
AN:
4814
European-Finnish (FIN)
AF:
0.299
AC:
3160
AN:
10560
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.221
AC:
15017
AN:
67994
Other (OTH)
AF:
0.166
AC:
351
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1113
2226
3338
4451
5564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
330
660
990
1320
1650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.201
Hom.:
10768
Bravo
AF:
0.158
Asia WGS
AF:
0.272
AC:
944
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
4.3
DANN
Benign
0.64
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16858988; hg19: chr2-171702960; API